Загрузка...
The impact of generic-only drug benefits on patients' use of inhaled corticosteroids in a Medicare population with asthma
BACKGROUND: Patients face increasing insurance restrictions on prescription drugs, including generic-only coverage. There are no generic inhaled corticosteroids (ICS), which are a mainstay of asthma therapy, and patients pay the full price for these drugs under generic-only policies. We examined cha...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2008
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2488344/ https://ncbi.nlm.nih.gov/pubmed/18638405 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6963-8-151 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|